Investor mix
14 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 36% |
| Other / undisclosed | 9 | 64% |
Developer of therapeutics for infectious diseases and cancer
14 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 36% |
| Other / undisclosed | 9 | 64% |